402 related articles for article (PubMed ID: 20509889)
1. The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study.
Andersen V; Ernst A; Christensen J; Østergaard M; Jacobsen BA; Tjønneland A; Krarup HB; Vogel U
BMC Med Genet; 2010 May; 11():82. PubMed ID: 20509889
[TBL] [Abstract][Full Text] [Related]
2. The Polymorphism rs3024505 (C/T) Downstream of the IL10 Gene Is Associated with Crohn's Disease in Serbian Patients with Inflammatory Bowel Disease.
Mijac D; Petrovic IV; Djuranovic S; Perovic V; Bojic D; Culafic D; Popovic D; Krstic M; Jankovic G; Djoric M; Pravica V; Markovic M
Tohoku J Exp Med; 2016 Sep; 240(1):15-24. PubMed ID: 27558476
[TBL] [Abstract][Full Text] [Related]
3. Genetic susceptibility in IBD: overlap between ulcerative colitis and Crohn's disease.
Doecke JD; Simms LA; Zhao ZZ; Huang N; Hanigan K; Krishnaprasad K; Roberts RL; Andrews JM; Mahy G; Bampton P; Lewindon P; Florin T; Lawrance IC; Gearry RB; Montgomery GW; Radford-Smith GL
Inflamm Bowel Dis; 2013 Feb; 19(2):240-5. PubMed ID: 23348120
[TBL] [Abstract][Full Text] [Related]
4. Association of T Helper 1 Cytokine Gene Single Nucleotide Polymorphisms with Ulcerative Colitis and Crohn's Disease.
Ebrahimi Daryani N; Sadr M; Soltani S; Saghazadeh A; Moossavi S; Shahkarami S; Farhadi E; Rezaei N
Dig Dis; 2019; 37(1):21-32. PubMed ID: 30134230
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-10-1082A/G polymorphism and inflammatory bowel disease susceptibility: a meta-analysis based on 17,585 subjects.
Zhu H; Lei X; Liu Q; Wang Y
Cytokine; 2013 Jan; 61(1):146-53. PubMed ID: 23046617
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2, multidrug resistance 1, and breast cancer resistance protein gene polymorphisms and inflammatory bowel disease in the Danish population.
Østergaard M; Ernst A; Labouriau R; Dagiliené E; Krarup HB; Christensen M; Thorsgaard N; Jacobsen BA; Tage-Jensen U; Overvad K; Autrup H; Andersen V
Scand J Gastroenterol; 2009; 44(1):65-73. PubMed ID: 18819034
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort.
Bank S; Andersen PS; Burisch J; Pedersen N; Roug S; Galsgaard J; Ydegaard Turino S; Brodersen JB; Rashid S; Kaiser Rasmussen B; Avlund S; Bastholm Olesen T; Hoffmann HJ; Andersen Nexø B; Sode J; Vogel U; Andersen V
PLoS One; 2015; 10(12):e0145302. PubMed ID: 26698117
[TBL] [Abstract][Full Text] [Related]
8. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
Mittal RD; Bid HK; Ghoshal UC
Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
[TBL] [Abstract][Full Text] [Related]
9. Distinct and overlapping genetic loci in Crohn's disease and ulcerative colitis: correlations with pathogenesis.
Waterman M; Xu W; Stempak JM; Milgrom R; Bernstein CN; Griffiths AM; Greenberg GR; Steinhart AH; Silverberg MS
Inflamm Bowel Dis; 2011 Sep; 17(9):1936-42. PubMed ID: 21830272
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner.
Tedde A; Laura Putignano A; Bagnoli S; Congregati C; Milla M; Sorbi S; Genuardi M; Papi L
Scand J Gastroenterol; 2008; 43(6):712-8. PubMed ID: 18569989
[TBL] [Abstract][Full Text] [Related]
11. Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn's disease.
Fiedler T; Büning C; Reuter W; Pitre G; Gentz E; Schmidt HH; Büttner J; Ockenga J; Gerloff T; Meisel C; Lochs H; Roots I; Köpke K; Johne A
Eur J Clin Pharmacol; 2007 Oct; 63(10):917-25. PubMed ID: 17665184
[TBL] [Abstract][Full Text] [Related]
12. Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy.
Bank S; Andersen PS; Burisch J; Pedersen N; Roug S; Galsgaard J; Turino SY; Brodersen JB; Rashid S; Rasmussen BK; Avlund S; Olesen TB; Hoffmann HJ; Nexø BA; Sode J; Vogel U; Andersen V
Pharmacogenomics J; 2018 Jan; 18(1):87-97. PubMed ID: 28139755
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-4 and Interleukin-10 Gene Polymorphisms in Patients with Inflammatory Bowel Disease.
Ebrahimi Daryani N; Saghazadeh A; Moossavi S; Sadr M; Shahkarami S; Soltani S; Farhadi E; Rezaei N
Immunol Invest; 2017 Oct; 46(7):714-729. PubMed ID: 28872970
[TBL] [Abstract][Full Text] [Related]
14. Significance of IL-1RA Polymorphism in Iranian Patients with Inflammatory Bowel Disease.
Daryani NE; Sadr M; Moossavi S; Shahkarami S; Soltani S; Farhadi E; Rezaei N
Dig Dis Sci; 2015 May; 60(5):1389-95. PubMed ID: 25466956
[TBL] [Abstract][Full Text] [Related]
15. Genetic association and epistatic interaction of the interleukin-10 signaling pathway in pediatric inflammatory bowel disease.
Lin Z; Wang Z; Hegarty JP; Lin TR; Wang Y; Deiling S; Wu R; Thomas NJ; Floros J
World J Gastroenterol; 2017 Jul; 23(27):4897-4909. PubMed ID: 28785144
[TBL] [Abstract][Full Text] [Related]
16. The effect of IL-10 genetic variation and interleukin 10 serum levels on Crohn's disease susceptibility in a New Zealand population.
Wang AH; Lam WJ; Han DY; Ding Y; Hu R; Fraser AG; Ferguson LR; Morgan AR
Hum Immunol; 2011 May; 72(5):431-5. PubMed ID: 21354456
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms present in IL10, IL23R, NOD2, and ATG16L1 associated with susceptibility to inflammatory bowel disease in Mexican population.
Quiroz-Cruz S; Posada-Reyes B; Alatorre-García T; Del Real-Calzada CM; García-Samper X; Escobar-Gutiérrez A; Vázquez-Chacón CA; Martínez-Guarneros JA; Cruz-Rivera M; Vaughan G; Fonseca-Coronado S
Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):10-16. PubMed ID: 31651650
[TBL] [Abstract][Full Text] [Related]
18. Associations between NRAMP1 Polymorphisms and Susceptibility to Ulcerative Colitis/Crohn's Disease: A Meta-Analysis.
Sun M; Zhang L; Shi S
Immunol Invest; 2016; 45(3):255-70. PubMed ID: 27019053
[TBL] [Abstract][Full Text] [Related]
19. The functional -765G→C polymorphism of the COX-2 gene may reduce the risk of developing crohn's disease.
de Vries HS; te Morsche RH; van Oijen MG; Nagtegaal ID; Peters WH; de Jong DJ
PLoS One; 2010 Nov; 5(11):e15011. PubMed ID: 21124790
[TBL] [Abstract][Full Text] [Related]
20. The association between three promoter polymorphisms of IL-10 and inflammatory bowel diseases (IBD): a meta-analysis.
Zou L; Wang L; Gong X; Zhao H; Jiang A; Zheng S
Autoimmunity; 2014 Feb; 47(1):27-39. PubMed ID: 24128120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
